Aripiprazole in Adolescents With Schizophrenia
Completed · Phase 3 · Has a placebo group
Conditions studied: Schizophrenia
In brief
The purpose of this trial is to test the safety and efficacy of aripiprazole in adolescent patients with schizophrenia for a period of at least 6 weeks.
Key facts
- Study ID
- NCT00102063
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- People needed
- 302
- Starts
- 2004-07-01
- Expected to finish
- 2006-08-01
- Last updated by the study team
- 2012-08-10
Who can join
Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Primary diagnosis of Schizophrenia 1
You may not qualify if…
- Patients diagnosed with schizoaffective disorder, major depressive disorder, delirium, or bipolar disorder
Where it is running
- Local Institution — Little Rock, Arkansas, United States
- Local Institution — Costa Mesa, California, United States
- Local Institution — Los Angeles, California, United States
- Local Institution — National City, California, United States
- Local Institution — Orange, California, United States
- Local Institution — Pasadena, California, United States
- Local Institution — Sacramento, California, United States
- Local Institution — San Diego, California, United States
- Local Institution — Temecula, California, United States
- Local Institution — Washington D.C., District of Columbia, United States
- Local Institution — Altamonte Springs, Florida, United States
- Local Institution — Fort Lauderdale, Florida, United States
- Local Institution — Gainesville, Florida, United States
- Local Institution — Hialeah, Florida, United States
- Local Institution — Jacksonville, Florida, United States
- Local Institution — Miami, Florida, United States
- Local Institution — North Miami, Florida, United States
- Local Institution — Orange City, Florida, United States
- Local Institution — Tampa, Florida, United States
- Local Institution — Newnan, Georgia, United States
- Local Institution — Smyrna, Georgia, United States
- Local Institution — Honolulu, Hawaii, United States
- Local Institution — Chicago, Illinois, United States
- Local Institution — Kansas City, Kansas, United States
- Local Institution — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.